Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 58353 [2014-23054]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 188 / Monday, September 29, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of issuance of 10 Final
Skin Notation Profile publications
ACTION:
Prevention and the Agency for Toxic
Substances and Disease Registry.
Centers for Disease Control and
Prevention
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
SUMMARY:
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
Substance(s)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of the
following 10 Skin Notation Profiles:
Allyl glycidyl ether: https://
www.cdc.gov/niosh/docs/2014-143/
pdfs/2014-143.pdf.
2-Diethylaminoethanol: https://
www.cdc.gov/niosh/docs/2014-140/
pdfs/2014-140.pdf.
2-Ethoxyethyl acetate: https://
www.cdc.gov/niosh/docs/2014-141/
pdfs/2014-141.pdf.
Ethyl acrylate: https://www.cdc.gov/
niosh/docs/2014-144/pdfs/2014144.pdf.
Isophorone diisocyanate: https://
www.cdc.gov/niosh/docs/2014-144/
pdfs/2014-144.pdf.
2-Mercaptobenzothiazole (MBT);
Sodium 2–MBT; Zinc 2–MBT: https://
www.cdc.gov/niosh/docs/2014-142/
pdfs/2014-142.pdf.
Methyl isocyanate: https://
www.cdc.gov/niosh/docs/2014-145/
pdfs/2014-145.pdf.
Nitrobenzene: https://www.cdc.gov/
niosh/docs/2014-146/pdfs/2014146.pdf.
Phenylhydrazine: https://
www.cdc.gov/niosh/docs/2014-147/
pdfs/2014-147.pdf.
Propargyl alcohol: https://
www.cdc.gov/niosh/docs/2014-149/
pdfs/2014-149.pdf.
These documents are
available at the following Web site:
https://www.cdc.gov/niosh/topics/skin/
skin-notation_profiles.html
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
tkelley on DSK3SPTVN1PROD with NOTICES
Naomi Hudson, Dr.P.H.: NIOSH, 1090
Tusculum Ave., MS–C32, Cincinnati,
OH 45226, Telephone: (513) 533–8540,
email: iuz8@cdc.gov.
Dated: September 22, 2014.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2014–23086 Filed 9–26–14; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
16:44 Sep 26, 2014
Jkt 232001
58353
Time and Date: 8:30 a.m.–3:00 p.m. (EDT),
October 23, 2014.
Place: CDC, Building 21, Rooms 1204 A/B,
1600 Clifton Road NE., Atlanta, Georgia
30333
Status: Open to the public, limited only by
the space and phone lines available. The
meeting room accommodates approximately
50 people. (Advance registration for inperson participation is required by October
16, 2014.) The public is welcome to
participate during the public comment
period, which is tentatively scheduled from
2:40 p.m. to 2:45 p.m. This meeting will also
be available by:
Teleconference: Please dial (877) 930–8819
and enter code 1579739.
Web links: Windows Media: (Closed
captioning will be available) https://
wm.onlinevideoservice.com/CDC1
Flash: https://www.onlinevideoservice.com/
clients/CDC/?mount=CDC3.
If you are unable to connect using the link,
copy and paste the link into your Web
browser. For technical support please call:
(404) 639–3737.
Purpose: The committee will provide
advice to the CDC Director on strategic and
other broad issues facing CDC.
Matters for Discussion: The Advisory
Committee to the Director will receive
updates from the State, Tribal, Local and
Territorial Subcommittee; the Health
Disparities Subcommittee, the Global
Workgroup, the Internal and External
Laboratory Safety Workgroups, and the
Public Health—Health Care Collaboration
Workgroup, the Ebola response, as well as an
update from the CDC Director. Agenda items
are subject to change as priorities dictate.
For More Information Contact: Carmen
Villar, MSW, Designated Federal Officer,
ACD, CDC, 1600 Clifton Road, NE., M/S D–
14, Atlanta, Georgia 30333. Telephone (404)
639–7158, Email: GHickman@cdc.gov. The
deadline to register for in-person attendance
at this meeting is October 16, 2014. To
register, please send an email to GHickman@
cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
[FR Doc. 2014–23054 Filed 9–26–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Board of
Scientific Counselors (BSC), Office of
Infectious Diseases (OID)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the BSC, OID. This board consists of
17 experts in fields related to infectious
diseases who are selected by the
Secretary of the U.S. Department of
Health and Human Services (HHS). The
board advises the HHS Secretary; the
CDC Director; the OID Director; and the
Directors of the National Center for
Immunization and Respiratory Diseases
(NCIRD), the National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP)
concerning strategies, goals, and
priorities for the programs and research
within the national centers; and
monitors the overall strategic direction
and focus of OID and the national
centers.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of the board’s
mission. Nominees will be selected by
the HHS Secretary or designee from
authorities knowledgeable in the fields
of infectious diseases and related
disciplines, including epidemiology,
microbiology, bacteriology, virology,
pathogen genomics, bioinformatics,
clinical medicine, and veterinary
medicine, as well as from the general
public. Members may be invited to serve
for terms of up to four years.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership shall be
balanced in terms of professional
training and background, points of view
represented, and the committee’s
function. In addition to a broad range of
expertise, consideration is given to a
broad representation of geographic areas
within the U.S., with diverse
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 79, Number 188 (Monday, September 29, 2014)]
[Notices]
[Page 58353]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23054]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 8:30 a.m.-3:00 p.m. (EDT), October 23, 2014.
Place: CDC, Building 21, Rooms 1204 A/B, 1600 Clifton Road NE.,
Atlanta, Georgia 30333
Status: Open to the public, limited only by the space and phone
lines available. The meeting room accommodates approximately 50
people. (Advance registration for in-person participation is
required by October 16, 2014.) The public is welcome to participate
during the public comment period, which is tentatively scheduled
from 2:40 p.m. to 2:45 p.m. This meeting will also be available by:
Teleconference: Please dial (877) 930-8819 and enter code
1579739.
Web links: Windows Media: (Closed captioning will be available)
https://wm.onlinevideoservice.com/CDC1
Flash: https://www.onlinevideoservice.com/clients/CDC/?mount=CDC3.
If you are unable to connect using the link, copy and paste the
link into your Web browser. For technical support please call: (404)
639-3737.
Purpose: The committee will provide advice to the CDC Director
on strategic and other broad issues facing CDC.
Matters for Discussion: The Advisory Committee to the Director
will receive updates from the State, Tribal, Local and Territorial
Subcommittee; the Health Disparities Subcommittee, the Global
Workgroup, the Internal and External Laboratory Safety Workgroups,
and the Public Health--Health Care Collaboration Workgroup, the
Ebola response, as well as an update from the CDC Director. Agenda
items are subject to change as priorities dictate.
For More Information Contact: Carmen Villar, MSW, Designated
Federal Officer, ACD, CDC, 1600 Clifton Road, NE., M/S D-14,
Atlanta, Georgia 30333. Telephone (404) 639-7158, Email:
GHickman@cdc.gov. The deadline to register for in-person attendance
at this meeting is October 16, 2014. To register, please send an
email to GHickman@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-23054 Filed 9-26-14; 8:45 am]
BILLING CODE 4163-18-P
